tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market

Inhibikase Therapeutics (IKT) Balance Sheet

Compare
167 Followers

Inhibikase Therapeutics Balance Sheet

Inhibikase Therapeutics's total assets for Q3 2024 were $4.38M, a decrease of -50.41% from the previous quarter. IKT total liabilities were $4.91M for the fiscal quarter, a 31.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 98.60M$ 14.51M$ 24.94M$ 42.47M$ 14.78M
Total Liabilities
$ 3.73M$ 3.53M$ 3.90M$ 4.05M$ 5.00M
Total Equity Gross Minority
$ 94.87M$ 10.98M$ 21.04M$ 38.42M$ 9.78M
Other Metrics
Currency in USD

Inhibikase Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis